Howton David T
SEC CIK 1529297 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| SLDB | Solid Biosciences Inc. | COO | 105.1K | — | $498.9K | 13 | 2023-12-02 | 2026-02-18 |
Most active insiders at SLDB, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Cumbo Alexander | Pres, CEO, Dir | — | $984.0K |
| 2 | Howton David T | COO | — | $433.6K |
| 3 | Tan Kevin | CFO, Treas | — | $329.5K |
| 4 | Hanrahan Jessie | Chief Regulatory Off | — | $297.4K |
| 5 | Brooks Gabriel | Chief Medical Off | — | $281.0K |
| 6 | Herzich Paul | CTO | — | $274.1K |
| 7 | Ganot Ilan | Dir | — | $82.4K |
| 8 | SMITH IAN F | Dir | — | — |
Transactions 13
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2026-02-18 | 2026-02-18 | SLDB | Solid Biosciences Inc. | Howton David T | COO | S - Sale+OE | $5.82 | -7,469 | 105.1K | -7% | -$43.5K |
| DT | 2026-02-18 | 2026-02-13 | SLDB | Solid Biosciences Inc. | Howton David T | COO | M - OptEx | — | +14.7K | 112.5K | +15% | — |
| T | 2026-02-06 | 2026-02-04 | SLDB | Solid Biosciences Inc. | Howton David T | COO | S - Sale | $6.44 | -18.9K | 97.9K | -16% | -$121.7K |
| DMT | 2026-02-02 | 2026-01-29+ | SLDB | Solid Biosciences Inc. | Howton David T | COO | M - OptEx | — | +121.6K | 112.2K | New | — |
| DT | 2026-02-02 | 2026-02-02 | SLDB | Solid Biosciences Inc. | Howton David T | COO | S - Sale+OE | $6.44 | -37.8K | 116.8K | -24% | -$243.2K |
| DT | 2025-12-04 | 2025-12-03 | SLDB | Solid Biosciences Inc. | Howton David T | COO | S - Sale+OE | $5.11 | -4,932 | 32.9K | -13% | -$25.2K |
| DT | 2025-12-04 | 2025-12-02 | SLDB | Solid Biosciences Inc. | Howton David T | COO | M - OptEx | — | +13.1K | 37.8K | +53% | — |
| DT | 2025-02-18 | 2025-02-13 | SLDB | Solid Biosciences Inc. | Howton David T | COO | M - OptEx | — | +14.7K | 30.4K | +94% | — |
| DT | 2025-02-18 | 2025-02-14 | SLDB | Solid Biosciences Inc. | Howton David T | COO | S - Sale+OE | $3.96 | -5,561 | 24.8K | -18% | -$22.0K |
| D | 2024-12-04 | 2024-12-02 | SLDB | Solid Biosciences Inc. | Howton David T | COO | M - OptEx | — | +13.1K | 20.7K | +170% | — |
| D | 2024-12-04 | 2024-12-03 | SLDB | Solid Biosciences Inc. | Howton David T | COO | S - Sale+OE | $5.60 | -5,072 | 15.7K | -24% | -$28.4K |
| D | 2023-12-05 | 2023-12-04 | SLDB | Solid Biosciences Inc. | Howton David T | COO | S - Sale+OE | $2.78 | -5,367 | 7,684 | -41% | -$14.9K |
| D | 2023-12-05 | 2023-12-02 | SLDB | Solid Biosciences Inc. | Howton David T | COO | M - OptEx | — | +13.1K | 13.1K | New | — |
Purchase Sale Sale after option exercise All abbreviations